A Study Of TeleGenetics Versus Usual Care To Increase Access To Cancer Genetic Services
| Status: | Active, not recruiting |
|---|---|
| Conditions: | Breast Cancer, Colorectal Cancer, Ovarian Cancer, Cancer, Cancer, Cancer |
| Therapuetic Areas: | Oncology |
| Healthy: | No |
| Age Range: | 18 - Any |
| Updated: | 9/29/2018 |
| Start Date: | August 2015 |
A Randomized Study Of TeleGenetics Versus Usual Care To Increase Access To Cancer Genetic Services
The goal of this research is to evaluate the relative advantage of remote counseling over
usual care in community health practices without access to genetic services. We will evaluate
ability of remote telemedicine, referred to going forward as TeleGenetic services (phone or
videoconferencing), to increase uptake of genetic testing and identification of genetic
carriers compared to usual care. Secondly, we will evaluate the advantages of
videoconferencing over telephone for delivery of remote genetic services and the short-term
and longitudinal outcomes of TeleGenetic services in socio-demographically diverse patients
in community practices.
usual care in community health practices without access to genetic services. We will evaluate
ability of remote telemedicine, referred to going forward as TeleGenetic services (phone or
videoconferencing), to increase uptake of genetic testing and identification of genetic
carriers compared to usual care. Secondly, we will evaluate the advantages of
videoconferencing over telephone for delivery of remote genetic services and the short-term
and longitudinal outcomes of TeleGenetic services in socio-demographically diverse patients
in community practices.
Inclusion Criteria:
1. Eligible participants will include adult men and women (aged 18 and older) who can
understand and communicate in English
2. meet National Comprehensive Cancer Network® criteria for cancer genetic testing for
breast, ovarian or colorectal cancers
3. have insurance coverage for genetic testing.
Exclusion Criteria:
1. Under 18 years old - professional guidelines do not recommend genetic testing for
cancer risk in minors.
2. Does not speak English.
3. Does not have insurance.
We found this trial at
1
site
3400 Civic Center Blvd
Philadelphia, Pennsylvania 19104
Philadelphia, Pennsylvania 19104
(215) 662-6065
Phone: 855-216-0098
Abramson Cancer Center of the University of Pennsylvania The Abramson Cancer Center of the University...
Click here to add this to my saved trials
